250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotech Startup Investors in Oceania

A list of 50 angel investors and VC funds that invest in Biotech startups based in Oceania. We rank investors based on the number of investments they made in Biotech companies from Oceania. We update this investor list every month.

Top 50 Biotech Startup Investors in Oceania

Investor Biotech Oceania investments
Uniseed Ventures 21
Brandon Capital 15
Medical Research Commercialisation Fund (MRCF) 11
Icehouse Ventures 7
Stoic VC 7
OneVentures 6
Main Sequence Ventures 5
New Zealand Venture Investment Fund 5
Finistere Ventures 5
Enterprise Angels 5
Artesian VC 5
Melbourne Angels 5
Horizons Ventures 4
K1W1 4
Matū Fund 3
Yuuwa Capital 3
OurCrowd 3
Starfish Ventures 3
Clean Energy Finance Corporation 3
Fonterra Co-operative Group 2
Callaghan Innovation 2
Possible Ventures 2
Allan Moss 2
Global Health Investment Fund (GHIF) 2
SOSV 2
BridgeLane Capital 2
Vectr 2
Brisbane Angels 2
Folklore Ventures 2
Sydney Angels 2
Empath Ventures 2
Rabobank Food & Agri Innovation Fund 2
Lowercarbon Capital 2
IP Group 2
Grok Ventures 2
Even Capital 1
CaraMed Capital 1
Marko Bogoievski 1
Powerhouse Ventures 1
Melanie Melanie 1
BioScience Managers Limited 1
David Ross 1
Powerhouse Ventures 1
Accelerating Commercialisation - AusIndustry 1
Investible 1
Victoria University of Wellington 1
HESTA 1
South Australian Venture Capital Fund 1
Skalata 1
NOAB Ventures 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Uniseed Ventures VC Fund · Brisbane, Queensland, Australia
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Funding Round
  • Australia, United States, United Kingdom
Portfolio highlights
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Morse Micro Breaks RecordWorld's Longest Wi-Fi HaLow Connection at 3 KilometersWatch Now Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah.
Brandon Capital VC Fund · Melbourne, Victoria, Australia · 2 investments in the past 12 months
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Entact Bio — Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
  • Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
  • Pathios Therapeutics — Pioneering a novel macrophage conditioning approach to delivering breakthrough cancer therapies
Medical Research Commercialisation Fund (MRCF) VC Fund · Melbourne, Victoria, Australia
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Glyscend — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Icehouse Ventures VC Fund · Auckland, Auckland, New Zealand · 10 investments in the past 12 months
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Seed, Series A, Funding Round
  • New Zealand, United States, Australia
Portfolio highlights
  • Aquila — We're powering the future by building and operating an infinitely scalable energy network.
  • NextWork — NextWork is developing the world's greatest online learning experience for switching careers.
  • Vertus Energy — We innovate to make fossil natural gas extinct.
Stoic VC VC Fund · Sydney, New South Wales, Australia
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Seed, Funding Round, Series A
  • Australia, United States, United Kingdom
Portfolio highlights
  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
  • Lenexa Medical — Lenexa Medical is driving towards better healthcare solutions for patients in hospital and aged-care by preventing pressure injuries and empowering clinicans.
OneVentures VC Fund · Sydney, New South Wales, Australia · 3 investments in the past 12 months
OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series A, Debt Financing, Funding Round
  • Australia, United States, Israel
Portfolio highlights
  • Hometime — At Hometime, we provide Airbnb property management solutions for homeowners and rental management business owners that help them scale and earn more.
  • StrongDM — Manage access to any server, database, or Kubernetes instance in minutes. Fully auditable, replayable, secure, and drag-and-drop easy.
  • Employment Hero — Employment Hero is Australia's top cloud-based HR, payroll and benefits platform for employers & employees. FREE trial for...
Main Sequence Ventures VC Fund · Sydney, New South Wales, Australia · 12 investments in the past 12 months
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Series A, Seed, Series B
  • Australia, Philippines, United States
Portfolio highlights
  • Xefco — Xefco is a company that develops novel textile and coating technologies. It uses a global network of research partners to develop advanced manufacturing solutions and apply cutting-edge materials science, with an emphasis on functional enhancements, sustainable manufacturing, and decreased resource consumption.
  • MGA Thermal — MGA Thermal, specialists in thermal energy storage technology. Renewable, high-power, economical, modular, safe and sustainable thermal storage solutions.
  • Cauldron Ferm — Cauldron is sustainably delivering the precision fermented prototypes of today to the supermarket shelves of tomorrow.
New Zealand Venture Investment Fund VC Fund · Auckland, Auckland, New Zealand
Your guide to finding and using government services.
Show more
Investment focus
  • Software, Biotechnology, SaaS
  • Seed, Series A, Angel
  • New Zealand, United States, Japan
Portfolio highlights
  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
  • Surgical Design Studios — The Insides Company is the leading provider of chyme reinfusion solutions for intestinal failure
Finistere Ventures VC Fund · San Diego, California, United States · 3 investments in the past 12 months
Finistere Ventures is an agricultural technology and life sciences venture capital investor. Founded in 2005, the company partners with other entrepreneurs and creative thinkers to build innovative companies that have the potential to transform modern agriculture, increase food security, improve nutrition, and enhance sustainability. Their appliedexperience as operators, and pioneering role in Ag Tech, is actively utilized to benefit its portfolio companies and Partners. Finistere has global access to the best new technologies from centers of Ag Tech excellence in the U.S., Australia, Israel, New Zealand, and Canada through its venture partner networks. Finistere’s locations in San Diego and Palo Alto, California keeps them connected to the centers of mainstream venture investment and the world’s leading innovation ecosystem.
Show more
Investment focus
  • Biotechnology, Agriculture, Farming
  • Series B, Series C, Series A
  • United States, New Zealand, Israel
Portfolio highlights
  • Jooules — Jooules offers a sustainable food system to ensure a greener, healthier future by using fermentation technologies to create nutritious protein ingredients.
  • Metrovate — Metrovate is a biotechnology company which enhance global health and sustainability via sophisticated research and development.
  • Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
Enterprise Angels VC Fund · Tauranga, Gisborne, New Zealand
Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Angel
  • New Zealand, United States, United Kingdom
Portfolio highlights
  • Cetogenix — Cetogenix is a clean technology business dedicated to creating long-term solutions to global climate change.
  • Yabble — Yabble provides a platform that uses machine learning and natural language processing to help brands connect with more than 62 million consumers globally, and collect data in real-time. Using the solution, clients can build their own surveys and manage their own customer research communities.
  • Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
Artesian VC VC Fund · Melbourne, Victoria, Australia · 6 investments in the past 12 months
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Pre-Seed
  • Australia, United States, Hong Kong
Portfolio highlights
  • Bygen — Bygen delivers high-quality activated carbon products while also facilitating large-scale, long-term carbon dioxide sequestration.
  • Sitemate — Sitemate builds user friendly software which thousands of industrial companies use every day to streamline their paperwork and processes.
  • Braingaze — Braingaze solves major challenges around cognitive disorders of the brain. We use a patented neuro-biomarker based on small involuntary eye movements. These are triggered by functional games, the resulting signal is analysed using algorithms trained by Deep Learning based on actual real patient / control cases. We adress pre-symptomatic stagesof Alzheimer's disease and the most common child cognitive disorder ADHD. Our tools are on the market and covered by a CE Mark as a medical device. Our pipeline includes detection / diagnostic tools as well as digital therapy solutions that have shown to reduce symtoms by over 50%.
Melbourne Angels VC Fund · Melbourne, Victoria, Australia
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more
Investment focus
  • Biotechnology, Information Technology, Manufacturing
  • Angel, Seed, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Apop Imaging — Apop Imaging develops and commercialises novel imaging, diagnostic and therapeutic tools to improve patient outcomes based on our proprietary calcitonin receptor antibody technology.
  • Alkira Software — Deliver interactive content and answer customer queries at scale using conversational AI. TalkVia offers quick and easy NO CODE voice and chat solutions for Amazon Alexa, Google Assistant, Siri and web based chatbots.
Horizons Ventures VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 17 investments in the past 12 months
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more
Investment focus
  • Biotechnology, Artificial Intelligence, Software
  • Series A, Series B, Seed
  • United States, United Kingdom, Canada
Portfolio highlights
  • Fano Labs — We are one of the leading AI companies specialising on Language AI technologies for enterprises in customer services, compliance and other lines of businesses.
  • Voyage Foods — Voyage Foods has made sustainable and scalable alternatives to foods that have current obstacles –environmental, social, and health alike. Our breakthrough technology provides endless opportunities to make delicious, nearly identical, versions of beloved foods, without compromising individual health or our planet. We replicated the world’s favoritefoods so that we can all enjoy them, forever.
  • Cauldron Ferm — Cauldron is sustainably delivering the precision fermented prototypes of today to the supermarket shelves of tomorrow.
K1W1 VC Fund · Auckland, Auckland, New Zealand · 2 investments in the past 12 months
K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.
Show more
Investment focus
  • Software, Biotechnology, SaaS
  • Seed, Series A, Funding Round
  • New Zealand, United States
Portfolio highlights
  • Akahu — Akahu provides open banking and open finance infrastructure. We make it simple for people to connect their financial accounts to trusted third parties.
  • Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
  • Lodestone Energy — Lodestone Energy builds and develops sustainable power production farms through solar energy market. It is based in Auckland, New Zealand.
Matū Fund VC Fund · Auckland, Auckland, New Zealand
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more
Investment focus
  • Biotechnology, Robotics, Nanotechnology
  • Seed
  • New Zealand, United States
Portfolio highlights
  • Ligar — Providing molecular filtration solutions to companies in the food, beverage, health, therapeutics, flavour and aroma industries. Our unique MIP and Polymer technology enables companies to improve their products and operational processes by extracting, reducing or concentrating flavours or compounds.
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • PowerON — Dielectric Elastomers for Soft Robotics
Yuuwa Capital VC Fund · Perth, Western Australia, Australia
Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.
Show more
Investment focus
  • Biotechnology, Analytics, Health Care
  • Series A, Seed, Series B
  • Australia
Portfolio highlights
  • Nexgen Plants Pty Limited — Healthy plants, healthy people, living planet. Nexgen develop's plants for future generations that will improve the environment and health of future generations.
  • icetana — icetana Motion Intelligence dramatically improves the active monitoring of security surveillance networks, with AI video anomaly detection and video analytics.
  • Agworld Pty Ltd — Agworld Farm Management software allows you to collect data at all levels and enables you to extract maximum value from this data; optimising profitability. The Agworld ecosystem is utilised by growers, agronomists and service providers on farms across the world.
OurCrowd VC Fund · Jerusalem, Yerushalayim, Israel · 11 investments in the past 12 months
Access exclusive venture capital angel investment deals in pre-vetted startup companies. Create your free OurCrowd investor account today!
Show more
Investment focus
  • Software, Artificial Intelligence, Machine Learning
  • Series B, Series A, Seed
  • Israel, United States, Canada
Portfolio highlights
  • Carrar — A complete thermal management solution for electric vehicles dissipating heat faster and more efficiently than ever before. Thermal management for ev batteries.
  • Jooules — Jooules offers a sustainable food system to ensure a greener, healthier future by using fermentation technologies to create nutritious protein ingredients.
  • Metrovate — Metrovate is a biotechnology company which enhance global health and sustainability via sophisticated research and development.
Starfish Ventures VC Fund · Melbourne, Victoria, Australia
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more
Investment focus
  • Software, Enterprise Software, Information Technology
  • Series A, Series B, Funding Round
  • United States, Australia, Philippines
Portfolio highlights
  • Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,219,508 freelance designers compete to create amazing designs for your business. Start Today!
  • Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Clean Energy Finance Corporation VC Fund · Sydney, New South Wales, Australia · 12 investments in the past 12 months
The Clean Energy Finance Corporation invests using a commercial approach to overcome market barriers and mobilize investment in renewable energy, energy efficiency, and low emissions technologies. They seek to catalyze and leverage private sector funding for the commercialization and deployment of clean energy technologies necessary for thetransition to a carbon-constrained economy.
Show more
Investment focus
  • Energy, Renewable Energy, Real Estate
  • Debt Financing, Series B, Seed
  • Australia, United States, Spain
Portfolio highlights
  • Plenti — When it comes to money, every decision counts. From what you borrow, and when you pay it back. To where you invest it, and how you make it go further. We’re on a mission to help everyone to make the right choices — about the choices that count.
  • Team Global Express — Team Global Express is a provider of a logistics platform for global supply chains. It offers real-time tracking, automated documentation, and end-to-end visibility that help international businesses optimize their operations and improve efficiency.
  • Downforce Technologies — Downforce Technologies is a pioneering leader in science-led, data-driven land management solutions focused on optimising soil health, soil organic carbon levels and biodiversity. With over 30% of the world's soil already degraded, urgent action is needed to address this pressing global challenge. Our platform offers a complete,high-resolution view of the land's carbon profile, enabling precise analysis and site-specific strategies for optimizing carbon levels.
Fonterra Co-operative Group VC Fund · Auckland, Auckland, New Zealand · 3 investments in the past 12 months
We're a global dairy nutrition company owned by 10,000 farmers and their families, united by a fundamental belief in the power of dairy to make a difference.
Show more
Investment focus
  • Food and Beverage, Nutrition, Dietary Supplements
  • Seed, Series B, Funding Round
  • Germany, New Zealand, United States
Portfolio highlights
  • Vivici — Our mission is to meet the world's growing need for sustainable, nutritious and great tasting animal-free proteins.
  • Jooules — Jooules offers a sustainable food system to ensure a greener, healthier future by using fermentation technologies to create nutritious protein ingredients.
  • Metrovate — Metrovate is a biotechnology company which enhance global health and sustainability via sophisticated research and development.
Callaghan Innovation VC Fund · 3 investments in the past 12 months
Callaghan Innovation is a stand-alone Crown Entity established on 1 February, 2013. Their role hasn’t previously existed in New Zealand.When they succeed, all New Zealanders will benefit from a stronger economy, higher value exports, more productive and sustainable resource use, more jobs and higher incomes.International evidence showsadvanced technology institutes like Callaghan Innovation have been successful at helping businesses build innovation capability that contributes to their growth and the broader economy.
Show more
Investment focus
  • AgTech, Construction, Horticulture
  • Seed, Pre-Seed, Funding Round
  • New Zealand
Portfolio highlights
  • Jooules — Jooules offers a sustainable food system to ensure a greener, healthier future by using fermentation technologies to create nutritious protein ingredients.
  • V-Quest — Ready For Carbon Emission Legislation and Compliance Reporting? BOOK A DEMO Future-Proof Your Business with our integrated carbon management solution. https://youtu.be/p6e-ipc2WnE?si=4DUICHKPShwW71j8 V-Quest V-Quest offers a stackable, integrated solution for carbon measurement, management, and reporting. It seamlessly fits into your existing software and workflow, is user-friendly, and saves you significant time, allowing you to focus on
  • Metrovate — Metrovate is a biotechnology company which enhance global health and sustainability via sophisticated research and development.
Possible Ventures VC Fund · Munich, Bayern, Germany · 16 investments in the past 12 months
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more
Investment focus
  • Software, Information Technology, Biotechnology
  • Seed, Pre-Seed, Series A
  • Germany, Australia, United States
Portfolio highlights
  • Insempra — Origin.Bio creates synthetic microorganisms that can make many of the same ingredients as traditional chemical industrialization processes today, but with significantly fewer energy requirements and waste produced while eradicating the need for petrochemicals.The company drives the convergence of engineering with biology, using DNA as theprogramming language. Rather than editing genetic material only in or out of DNA, engineers can hack entirely new organisms that have never existed — all powered by computing, automation, and artificial intelligence (AI)/machine-learning while leveraging millions of years of evolution. Operating at an atomic level, the company farms organisms with microscopic precision and integrates them into existing original equipment manufacturer (OEM) manufacturing processes. This asset-light approach enables Origin.Bio to generate sustainable materials at speed in a cost-effective way, without compromising on performance.
  • Sumday — Non - financial accounting software. Start carbon accounting, properly, with the support of your existing advisors
  • InSpacePropulsion Technologies — ISPTech is a Spin-Off of the Institute of Space Propulsion at the German Aerospace Center (DLR). It offers non-toxic, green propulsion solutions
Allan Moss Angel · Sydney, New South Wales, Australia
Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Funding Round, Series A, Seed
  • Australia, United States, The Netherlands
Portfolio highlights
  • Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
Global Health Investment Fund (GHIF) VC Fund · New York, New York, United States
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series B, Series C, Funding Round
  • United States, India, Austria
Portfolio highlights
  • Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
  • CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
SOSV VC Fund · Princeton, New Jersey, United States · 95 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • NovoNutrients — NovoNutrients is working to turn waste CO2 into high-value, low-cost proteins and additives for food and feed by developing proprietary microbes and advanced gas fermentation systems.
  • OncoPrecision — We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity and Resistance Test, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access toPrecision Oncology and improve cancer patients' lives.
  • Sodex Innovations — Sodex Innovations is a company which is specialized in developing assistance-systems and automating-kits for excavators
BridgeLane Capital VC Fund · Sydney, New South Wales, Australia
The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme
Show more
Investment focus
  • Software, Financial Services, Health Care
  • Seed, Series B, Funding Round
  • Australia, Germany
Portfolio highlights
  • Agerris — Agerris is a field robotics and AI start-up for the agriculture industry, based on technology created at the Australian Centre for Field Robotics, the University of Sydney, where they have been developing air and ground robotic solutions for the agriculture industry since 2005.
  • Sprout Stack
  • Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Vectr VC Fund · Sheung Wan, Hong Kong Island, Hong Kong · 2 investments in the past 12 months
Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.
Show more
Investment focus
  • FinTech, Financial Services, Artificial Intelligence
  • Seed, Series A, Pre-Seed
  • United States, Hong Kong, Singapore
Portfolio highlights
  • Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
  • Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
  • MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Brisbane Angels VC Fund · Brisbane, Queensland, Australia · 3 investments in the past 12 months
Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.
Show more
Investment focus
  • Information Technology, Software, Artificial Intelligence
  • Seed, Angel, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • PropCode — PropCode is a online platform, that helps in researching for town planning queries. the rules can be complex, and make it easy to get the right answers.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Apollo Secure — Cyber for Humans - an automated cybersecurity platform for startups and small businesses to improve security maturity and simplify security compliance.
Folklore Ventures VC Fund · Sydney, New South Wales, Australia
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Show more
Investment focus
  • Software, Apps, Information Technology
  • Seed, Series A, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • Kry10 — Kry10 is a safe operating system for SDMs.It makes the transition to an intelligent, cloud-connected, and adaptively driven future possible for automobiles, electricity grids, satellites, and medical equipment.
  • HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
  • SimConverse — SimConverse is a simulation platform that uses generative AI to play the role of any patient, colleague or casualty.
Sydney Angels VC Fund · Sydney, New South Wales, Australia
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more
Investment focus
  • Software, SaaS, Apps
  • Seed, Funding Round, Angel
  • Australia, United States
Portfolio highlights
  • Remi AI — A.I-Powered Demand Forecasting, Supply Chain AI, & Price Optimisation | Remi AI
  • Trendspek — Trendspek's 3D software lets you manage high-value built assets faster, safer and with more accuracy. With millimetre detail, interact with exact digital replicas of infrastructure from your desk and collaborate with global stakeholders. Book a call with us to get started.
  • Apollo Secure — Cyber for Humans - an automated cybersecurity platform for startups and small businesses to improve security maturity and simplify security compliance.
Empath Ventures VC Fund · Los Angeles, California, United States · 3 investments in the past 12 months
Empath Ventures is a venture capital firm that mainly invests in psychedelic medicine companies. The firm specializes in the fields of investment financial services, finance, and venture capital. It was founded in 2021 and headquartered in Los Angeles California.
Show more
Investment focus
  • Health Care, Biotechnology, Personal Health
  • Seed, Convertible Note, Series A
  • United States, United Kingdom, Canada
Portfolio highlights
  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • TARA Mind — TARA Mind enables safe, effective, affordable mental health therapies with a premium network of therapists and ketamine clinics.
  • Motif Neurotech — Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses.
Rabobank Food & Agri Innovation Fund VC Fund · Utrecht, Utrecht, The Netherlands
Rabobank emerged from several small agricultural cooperative banks, founded by Dutch farmers in the late nineteenth century. Food & Agriculture (F&A) is in our DNA, from which we built a unique position in the F&A sector as a key financier and international player, attributes which we leverage for the benefit of our stakeholders andportfolio companies. We recognise and understand the food security challenges lying ahead of us and how Innovation in F&A supply chains is key to the solution, which is why we are dedicated to committing capital to the space.
Show more
Investment focus
  • Agriculture, AgTech, Farming
  • Series A, Series B, Seed
  • United States, The Netherlands, Canada
Portfolio highlights
  • 30MHz — The data platform for horticulture | Sense. Act. Impact.
  • BeeHero — BeeHero - Your precision pollination provider for almonds, berries, apples and more We raise and keep exceptional bees by combining generations of commercial beekeeping experience with cutting-edge technology. Get premium bees & pollinate your crops with precision.
  • EarthOptics — EarthOptics is building the cloud-based machine learning platform for soil and ground management.
Lowercarbon Capital VC Fund · New York, New York, United States · 16 investments in the past 12 months
Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.
Show more
Investment focus
  • Biotechnology, Renewable Energy, Energy
  • Seed, Series A, Series B
  • United States, United Kingdom, France
Portfolio highlights
  • Zanskar — Zanskar develops a predictive platform informed by massive data for discovering previously unknown geothermal resources. Its platform includes subsurface characterization technology and massive data sets, enhancing and reducing risk in the exploration of geothermal resources.
  • Mosa Meat — Mosa Meat produces slaughter-free hamburgers. The burger is harvested from cow cells, rather than raising and slaughtering a whole animal. By growing meat naturally from cells, Mosa Meat strives to accelerate the transition to a truly sustainable global food system.
  • Xcimer Energy — Xcimer Energy offers a laser-driven fusion to provide cheap, abundant, and carbon-free energy. It is used to transform the energy marketplace that integrates low-cost excimer laser technology with the HYLIFE reaction chamber concept to design an Inertial Fusion Energy (IFE) system. This system overcomes long-standing obstacles to viable fusionpower.The company was founded in 2021 and is headquartered in Redwood City,, California.
IP Group VC Fund · London, England, United Kingdom · 2 investments in the past 12 months
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more
Investment focus
  • Health Care, Biotechnology, Therapeutics
  • Seed, Series A, Series B
  • United Kingdom, United States, Australia
Portfolio highlights
  • AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
  • Enterprise Therapeutics — Enterprise Therapeutics is a drug discovery company dedicated to the researchand development of novel therapies for the treatment of respiratory diseases.In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlyingmechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
Grok Ventures VC Fund · Surry Hills, New South Wales, Australia · 3 investments in the past 12 months
Backing a better tomorrow
Show more
Investment focus
  • Renewable Energy, Software, Biotechnology
  • Series A, Series B, Seed
  • Australia, United States, Hong Kong
Portfolio highlights
  • Gridmo — gridmo accelerates the connection of generation to the grid. Unlock access to fast and accurate power system studies.
  • Lydian — Lydian aims to accelerate the decarbonization of the chemical industry by electrifying the chemical production process. Founded in 2021 by Branko Zugic, Lydian is headquartered in
  • Antora Energy — Antora converts low-cost, intermittent renewable electricity into a reliable, on-demand source of zero-emissions industrial heat and power.
Even Capital VC Fund
Even Capital operates as an investment firm.
Show more
Investment focus
  • FinTech, Biotechnology, Product Research
  • Seed, Series C
  • New Zealand
Portfolio highlights
  • Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
  • Sharesies — Sharesies allows you to get started investing from just $5.
CaraMed Capital VC Fund · Auckland, Auckland, New Zealand
CaraMed Capital is a deep-health tech venture capital fund.
Show more
Investment focus
  • Biotechnology
  • Seed
  • Australia
Portfolio highlights
  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
Marko Bogoievski Angel
Marko retired as CEO of Morrison & Co in 2021 after 13 years of leading the business. He continues to provide guidance for investments in telecommunications and digital infrastructure. His 30 year career has been in the infrastructure and technology sectors in a variety of senior finance, operational and sales roles in the United States and NewZealand. Prior to joining Morrison & Co in 2008, Marko was CFO of Telecom NZ, responsible for corporate finance, M&A and group strategy. Marko is Chair of Vodafone New Zealand.
Show more
Investment focus
  • Biotechnology, Manufacturing
  • Funding Round
  • New Zealand
Portfolio highlights
  • Pictor — Pictor is a biotechnology company develops, manufactures and market immunodiagnostic products.
Powerhouse Ventures VC Fund · Oakland, California, United States · 5 investments in the past 12 months
Powerhouse Ventures backs entrepreneurs building the digital infrastructure for rapid decarbonization.
Show more
Investment focus
  • Software, Energy, Solar
  • Seed, Series A, Pre-Seed
  • United States, Australia, United Kingdom
Portfolio highlights
  • SHAED — SHAED offers a mobility platform. It focuses on Shared, Hydrogen, Autonomous, Electric, and Distribution technologies. It speeds up the shift from traditional engines to electric and sustainable vehicles in the commercial sector.
  • ThinkLabs AI — ThinkLabs AI is a specialist AI development and deployment firm. Its mission is to empower critical industries and infrastructure with trustworthy AI towards global energy sustainability.
  • Sesame Sustainability — Sesame Sustainability is a SAAS company that offers industrial decarbonization platform for modeling, optimization, and analysis.
Melanie Melanie Angel · Wellington, Wellington, New Zealand
Investor
Show more
Investment focus
  • Biotechnology, Product Research
  • Seed
  • New Zealand
Portfolio highlights
  • Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
BioScience Managers Limited VC Fund · Melbourne, Victoria, Australia
BioScience Managers Pty Ltd (formerly IB Managers) is a leading life sciences investment firm, headquartered in Melbourne, Australia. Established in 2003, BioScience Managers offers a global, multi-disciplinary team, bringing an international perspective together with the track record, networks and expertise required to convert that perspectiveinto informed, high return investment decisions.We operate a high value-add model, providing assistance and support to portfolio companies via our global team and international network of independent industry advisors. With combined experience of over 170 investments, more than 40 IPO’s/ reversals in Europe, the USA and Australia, and a diverse skillset specific to the bio-based industries, we aim to provide investee companies with significant value-add over and above capital invested.Alongside our funds management business, Phillip Bioscience Advisory provides specialist corporate advisory services to healthcare and life sciences companies.
Show more
Investment focus
  • Health Care, Pet, Medical
  • Funding Round
  • Canada, Australia
Portfolio highlights
  • Nexvet — Our mission is to be a revolutionary force in the growing US$25 billion global animal pharmaceutical market. Only Nexvet can produce therapeutic antibodies that are 100% customised to target new species – like cats and dogs.Monoclonal antibody therapies have represented a new generation of highly effective, safe and targeted medicines inhumans. We think it’s time companion animals reaped the benefits of human medical progress in this field.Nexvet’s unique technology, PETisation™, ensures 100% customisation of a therapy to a new species, reducing the chances of immune challenges, and ensuring a more ‘natural’ fit between the therapy and the patient. Many chronic conditions in pets remain poorly treated by current veterinary therapies, such as pain and various inflammatory diseases– which has guided Nexvet’s focus towards these indications.To ensure we succeed in transforming animal medicine, we’ve brought together a team with an extraordinary global track record in animal and human health. We are working with leading contractors, advisors, drug development partners, academic groups, veterinarians and animal interest groups around the world to develop our pipeline to the highest standards.Senior executives and researchers from the world’s largest animal health brands are counted among our Board, management, and advisors, and together we’re building connections worldwide to make our vision a reality.
  • Canary Medical — Canary is giving medical devices a voice and letting medical data be heard.
  • Millenium Biologix — Millenium Biologix Corporation operates as a biomedical company primarily in the United States and Europe. It engages in the development and commercialization of implantable medical devices and skeletal tissue regeneration products for various orthopedic uses. The company offers Skelite, a synthetic bone graft, for healing and replacement.Millenium Biologix also develops Primacoll and Peptos for the stimulation of bone tissue growth. In addition, it offers ACTES, a cell culture and tissue engineering system, which provides automated control over the biological process of tissue engineering. The company was founded in 1986 and is headquartered in Kingston, Canada.
David Ross Angel
David Ross
Show more
Investment focus
  • Biopharma, Biotechnology
  • Seed
  • New Zealand
Portfolio highlights
  • Helico — Helico is developing a proprietary computational platform for synthetic biology research using modelling tools and AI-based prediction algorithms. The long-term aim is to develop a seed bank of different drugs able to be licensed to grow medical supplies in confined greenhouses anywhere in the world.
Powerhouse Ventures VC Fund · Christchurch, Canterbury, New Zealand · 2 investments in the past 12 months
powerHouse is a New Zealand intellectual property commercialisation company investing to develop new spin-out ventures
Show more
Investment focus
  • Solar, FinTech, Big Data
  • Seed, Series A, Funding Round
  • United States, France, New Zealand
Portfolio highlights
  • Granular — Granular Energy provides solutions for managing and trading clean energy. We are the leading provider of energy certificate management software for utilities, helping to streamline certificate managment processes and enabling utilities to launch next-generation green offers, including transparency down to the hourly level.
  • Granular Energy — Granular Energy provides solutions for managing and trading clean energy. We are the leading provider of energy certificate management software for utilities, helping to streamline certificate managment processes and enabling utilities to launch next-generation green offers, including transparency down to the hourly level.
  • Salient Predictions — Salient Predictions uses ML & ocean data to provide long range weather forecast for use in diverse industries.
Accelerating Commercialisation - AusIndustry VC Fund · Canberra, Australian Capital Territory, Australia
A grant program offered by AusIndustry as part of the Australian Government’s National Innovation and Science Agenda
Show more
Investment focus
  • Software, Mining, Hardware
  • Grant, Pre-Seed
  • Australia
Portfolio highlights
  • Neuromersiv — Neuromersiv empowers stroke and brain injury survivors with clinically designed virtual reality-based neurological rehabilitation solutions.
  • Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
Investible VC Fund · Sydney, New South Wales, Australia · 18 investments in the past 12 months
Investible is an early-stage venture capital firm backing the visionaries advancing humanity through technology in Australia, New Zealand, Southeast Asia and globally.
Show more
Investment focus
  • Software, E-Commerce, Information Technology
  • Seed, Series A, Pre-Seed
  • Australia, United States, Singapore
Portfolio highlights
  • Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
  • Restoplus — Checkout our point of sale, website, online ordering, qr code table ordering, and table booking. Contact our experts to learn more.
  • Betterdata — Better Data Our technology makes data sharing instant and secure by converting limited real data into limitless synthetic data that looks, feels behaves just like real data
Victoria University of Wellington VC Fund · Wellington, Wellington, New Zealand
A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Seed
  • Australia
Portfolio highlights
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
HESTA VC Fund · Melbourne, Victoria, Australia
HESTA Super Fund is the Australian industry superannuation fund for people working in health and community services. Become a member today.
Show more
Investment focus
  • Sensor, Medical, Aerospace
  • Series A, Series B, Series C
  • Australia
Portfolio highlights
  • Baraja — Baraja is a deep technology company that has reinvented LiDAR for self-driving vehicles. Our patented platform, Spectrum-Scan™, takes a fundamentally different approach to LiDAR. Instead of relying on fragile moving parts and oscillating mirrors, we simply refract light through a prism to scan the environment. This patented method allows us todeliver unprecedented range, precision, and reliability in even the most extreme environments.
  • Citadel Group Ltd — Citadel develops and delivers technology and education solutions to state and federal government departments, and the private sector in Australia. The company operates through Technology and Education segments. The Technology segment sells professional and managed services to government agencies and private enterprises. Its services includestrategic advice, program management, acquisition support, and quality assurance services through consulting, contracting, and placement mechanisms; technology and integration services; and software solutions, products, and managed services for digital health, diagnostic laboratories, and clinical applications. The Education segment delivers a range of nationally-accredited business qualifications that enable students to articulate into second year university or to gain practical skills for employment.
  • Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
South Australian Venture Capital Fund VC Fund · Adelaide, South Australia, Australia
South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.
Show more
Investment focus
  • Health Care, Biotechnology, SaaS
  • Funding Round, Series A, Series B
  • Australia
Portfolio highlights
  • Lumary — Simplify Your Care Management Optimise Your Organisation Create Better Wellbeing
  • BiomeBank — BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Skalata VC Fund · Melbourne, Victoria, Australia · 6 investments in the past 12 months
Giving Australian founders access to the education, capital and networks needed to build significant, sustainable, global businesses of the future.
Show more
Investment focus
  • Software, Information Technology, Education
  • Pre-Seed, Seed
  • Australia, United States, United Kingdom
Portfolio highlights
  • Nucanon — Narrative design software for game developers
  • Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
  • Omni Biotech — Omni Biotech builds health and performance algorithms that work on all hardware platforms.
NOAB Ventures VC Fund
NOAB Ventures operates as a venture capital firm.
Show more
Investment focus
  • Solar, Energy, Biofuel
  • Pre-Seed, Seed, Funding Round
  • Australia, New Zealand
Portfolio highlights
  • Relectrify — Unlocking extra lifetime and performance of batteries via advanced battery management (BMS) technology.
  • Vertus Energy — We innovate to make fossil natural gas extinct.
  • HydGene Renewables — HydGene Renewables mission is to accelerate adoption of low carbon technology by providing an alternative green hydrogen solution.
Investors by industry
Investors by country
Investors in Oceania by industry